An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus
review
OA: gold
CC0
⤵ 11 in-corpus citations
AI-generated summary
This review summarizes current literature on the safety and efficacy of uterine artery embolization for treating uterine leiomyomata and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Uterine artery embolization (UAE) is an established technique to treat benign diseases of the uterus such as uterine leiomyomata (fibroids) and adenomyosis. This article reviews the use of UAE in these conditions and summarizes the evidence regarding safety and efficacy of the technique based on the current literature.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients via openalex
- Clinical investigation of fertility after uterine artery embolization via openalex
- Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Differences in clinical characteristics for the determination of adenomyosis coexisting with leiomyomas via openalex
- Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up via openalex
- How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex
- Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis via openalex
- Long‐term durability of uterine artery embolisation for treatment of symptomatic adenomyosis via openalex
- Long-Term Follow-up of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- MRI of Adenomyosis: Changes with Uterine Artery Embolization via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis via openalex
- Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes via openalex
- Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- Risk factors for adenomyosis via openalex
- Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis via openalex
- Surgery in adenomyosis via openalex
- The Outcome of Fertility-Sparing and Nonfertility-Sparing Surgery for the Treatment of Adenomyosis. A Systematic Review and Meta-analysis via openalex
- Transvaginal sonographic features of diffuse adenomyosis in 18–30‐year‐old nulligravid women without endometriosis: association with symptoms via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- Uterine artery embolisation for symptomatic adenomyosis—Mid-term results via openalex
- Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL Questionnaire via openalex
- Uterine artery embolization for adenomyosis without fibroids via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis: A New Technical Development of the 1-2-3 Protocol and Predictive Factors of MR Imaging Affecting Outcomes via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis with or without Uterine Leiomyomas with the Use of Calibrated Tris-acryl Gelatin Microspheres: Midterm Clinical and MR Imaging Follow-up via openalex
- Uterine Artery Embolization for the Treatment of Adenomyosis via openalex
- Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis via openalex
- Uterine artery embolization or myomectomy for women with uterine fibroids: Four-year follow-up of a randomised controlled trial via openalex
- Uterine Artery Embolization to Treat Uterine Adenomyosis with or without Uterine Leiomyomata: Results of Symptom Control and Health-Related Quality of Life 40 Months after Treatment via openalex
- Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Adenomyosis: Protocol for the Randomized QUESTA Trial via openalex
- Uterine Artery Embolization with Small-Sized Particles for the Treatment of Symptomatic Adenomyosis: A 42-Month Clinical Follow-Up via openalex
- W2592559255 via openalex
- W2593039806 via openalex
- W2602082991 via openalex
- W2765546885 via openalex
- W2766095091 via openalex
- W2790094279 via openalex
- W2790144109 via openalex
- W2797670901 via openalex
- W2898113690 via openalex
- W2898817287 via openalex
- W2914896623 via openalex
- W2943197583 via openalex
- W2947626646 via openalex
- W2947911129 via openalex
- W2948639806 via openalex
- W2972485226 via openalex
- W2978586042 via openalex
- W2990809879 via openalex
- W3002894142 via openalex
- W3010705033 via openalex
- W3015078206 via openalex
- W3015223497 via openalex
- W3043445146 via openalex
- W3045490689 via openalex
- W3081034339 via openalex
- W3093774512 via openalex
- W3103316420 via openalex
- W3113866254 via openalex
- W3121294876 via openalex
- W3122166030 via openalex
- W3128659698 via openalex
- W3135378813 via openalex
- W3179975141 via openalex
- W1542775365 via openalex
- W4255664903 via openalex
- W1949976355 via openalex
- W1963621667 via openalex
- W1964063041 via openalex
- W1970457859 via openalex
- W1972093569 via openalex
- W1978287423 via openalex
- W1996284739 via openalex
- W2002544923 via openalex
- W2022109007 via openalex
- W2023952454 via openalex
- W2033952229 via openalex
- W2035346924 via openalex
- W2038354928 via openalex
- W2038950921 via openalex
- W2042515108 via openalex
- W2047520742 via openalex
- W2050942978 via openalex
- W2066440583 via openalex
- W2073670906 via openalex
- W2089047115 via openalex
- W2105882735 via openalex
- W2112920670 via openalex
- W2113313274 via openalex
- W2115618696 via openalex
- W2124126126 via openalex
- W2134037483 via openalex
- W2134633087 via openalex
- W2146646184 via openalex
- W2150358681 via openalex
Cited by (11)
- Adenomyosis and Endometriosis: Two Faces of the Same Disease? 2026
- Adenomyosis with abnormal uterine bleeding complicated by venous thrombosis: a case series and literature review 2025
- The impact of embolization endpoints on the efficacy of uterine artery embolization for adenomyosis 2025
- Vascular and Nonvascular Interventions in Gynecology 2025
- Uterine Artery Embolization as an Alternative Therapeutic Option in Adenomyosis: An Observational Retrospective Single-Center Study 2025
- Treatment-related changes in adenomyosis: a primer for radiologists 2025
- Image-guided therapies for uterine fibroids 2025
- Effect of uterine artery embolization therapy on ReHo values in brain regions related to pain perception and emotion regulation in adenomyosis patients accompanied by dysmenorrhea 2025
- Alternative treatments of adenomyosis – an update in procedural management and clinical outcomes 2024
- Update on Endovascular Therapy for Fibroids and Adenomyosis 2023
- Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years 2023
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-12T06:13:25.972923+00:00
License: CC0
· commercial use OK